Reports of carbapenem-resistant Enterobacteriaceae (CRE) infections related to endoscopic retrograde cholangiopancreatography (ERCP) duodenoscopes raised concerns among infection prevention experts, federal agencies, and the public. In February 2015, Ronald Reagan UCLA Medical Center notified 179 patients who underwent ERCP that they may have been exposed to CRE from contaminated duodenoscopes. Ronald Reagan UCLA Medical Center reported that only patients who underwent ERCP procedures from October 3, 2014, to January 28, 2015, were at risk of CRE infection as a result of these procedures. UCLA Medical Center noted that it processed the scopes according to the standards stipulated by the manufacturer. As of February 23, a total of seven UCLA patients were infected and two died.
Learn more about the safety of endoscopes and validity of manufacturer guidance.